Outpatient Surgery Magazine

Product & Services Showcase - November 2017

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://magazine.outpatientsurgery.net/i/893092

Contents of this Issue

Navigation

Page 10 of 11

Nozin.com 877-669-4648 To contact your Nozin advisor and for professional samples: LEADER IN NASAL DECOLONIZATION ™ Better Care. Lower Costs. No Antibiotics or Iodine. Nozin IP Protocols ™ GIVE YOUR BUNDLE A BOOST Existing IP Bundle I N F E C T I O N R A T E with Nozin 81% SSI reduced y Address Pre-Op and Post-Op SSI Risk y Low Cost, Pleasant Decolonization y Can Include Use by Sta!, Caregivers y Antibiotic Stewardship Support Nozin 360™ Infection Prevention Protocols o!er more: sustained patient nasal decolonization as well as use by sta! and caregivers for extra protection. This has been shown to reduce infections signi"cantly. 1 It can address SSI risk pre-op through post-op recovery, even at home after discharge, without antibiotics or iodine. Nozin® Nasal Sanitizer® antiseptic combines ethanol with moisturizing emollients and is proven to decolonize nasal S. aureus day one. 2 Give your surgery infection prevention a boost with Nozin 360™ IP protocols. 81% SSI reduction. 1 1. Mullen A, et al. Perioperative participation of orthopedic patients and surgical sta!. AJIC, 2017: Vol 45, Issue 5, 554 - 6.. 2. Steed L, et al. Reduction of nasal Staphylococcus aureus carriage. AJIC, 2014: 42(8): 841-6. ©2017 Global Life Technologies Corp. All rights reserved. Made in USA. Nozin®, Nasal Sanitizer®, 360™, Leader in Nasal Decolonization are trademarks of Global Life Technologies Corp. Nozin® Nasal Sanitizer® antiseptic is an OTC topical drug and no claim is made that it has an e!ect on any speci"c disease. ™

Articles in this issue

Links on this page

Archives of this issue

view archives of Outpatient Surgery Magazine - Product & Services Showcase - November 2017